Johnson & Johnson (JNJ) Short-term Investments (2009 - 2026)

Johnson & Johnson has disclosed Short-term Investments across 18 years of filings, most recently posting $363.0 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $363.0 million, up 18.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $363.0 million (up 18.24% YoY), and the FY2025 annual result was $393.0 million, down 5.76% from the prior year.
• Short-term Investments came in at $363.0 million for Q1 2026 at Johnson & Johnson, down from $393.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $22.7 billion in Q4 2022 to a low of $303.0 million in Q2 2025.
• The 5-year median for Short-term Investments is $906.5 million (2023), against an average of $6.2 billion.
• Across the five-year window, Short-term Investments soared 96.69% in 2022 and sank 91.85% in 2024, its largest moves.
• Johnson & Johnson's Short-term Investments stood at $22.7 billion in 2022, then slumped by 95.3% to $1.1 billion in 2023, then sank by 60.96% to $417.0 million in 2024, then declined by 5.76% to $393.0 million in 2025, then slipped by 7.63% to $363.0 million in 2026.
• The last three Short-term Investments figures came in at $363.0 million (Q1 2026), $393.0 million (Q4 2025), and $331.0 million (Q3 2025), per Business Quant data.